Two hundred and seventy patients underwent anaesthesia for 280 renal transplants between October 1977 and October 1982. Their medical records were studied retrospectively. These patients were representative of the end-stage chronic renal failure population, with the usual high incidence of cardiovascular and biochemical abnormalities. Most received general anaesthesia, with an intravenous barbiturate, muscle relaxant, narcotic and volatile supplement sequence being the most common. There were no intra-operative deaths. One postoperative death was felt to be influenced by the anaesthetic management. Four patients had life-threatening cardiac complications and a further four required postoperative respiratory support, three for delayed recovery of neuromuscular function and one for "recurarisation". Less serious complications were considerably more common. General anaesthesia utilising suxamethonium and tubocurarine as the relaxants and halothane as the volatile supplement is least likely to result in complications. Changes to this anaesthetic sequence are likely with the introduction of new agents.
The emphasis placed on renal transplantation for the treatment of end-stage renal failure has made anaesthesia for this operation relatively common in Australasia. I In 1982, 76 patients received homograft kidneys at the Princess Alexandra Hospital, the centre for transplantation for the State of Queensland. The per capita transplantation rate (30 cases per million) is amongst the highest in the world.
When renal transplantation was introduced nearly 30 years ago, recipients usually manifested the pre-terminal symptoms and signs of chronic renal failure and were often severely ill. Preoperative dialysis was uncommon. 2 The successful administration of anaesthesia to these patients seems in retrospect to have been a considerable achievement. Over the succeeding years, great improvements have been made in the management of renal failure. Dialysis aids optimal preparation of patients for transplantation. Currently, patients presenting for renal transplantation are in much better condition than previously, but still represent poor risks when compared with the general surgical population. 3 . 6 Between October 1977 and October 1982, anaesthesia was administered to 270 patients for 280 renal transplants. Their records were studied retrospectively. The aim of the study was to examine complications occurring both during and after operation which were either caused by the anaesthetic technique or which were exacerbated by it. In this way it was hoped to identify the anaesthetic sequence least likely to result in problems.
PATIENTS AND METHODS There were 124 females and 156 males of whom 43 were undergoing their second and 3 their third transplants. In two cases, the procedure was abandoned after induction, once for surgical and once for anaesthetic reasons. Most patients received cadaveric kidneys; four patients received kidneys from live related donors. The primary causes of chronic renal failure are listed in Table 1 . The mean age was 41 years (S.D. 13.4; n = 280; range 8 to 63 years). The mean weight was 61.9 kg (S.D. 14.4; n = 266; range 16 to 112 kg). Two hundred and thirty-three patients were on haemodialysis, 33 on peritoneal dialysis, and one was about to commence dialysis. One 19 3 3 2 ·Some patients were receiving two or more drugs hundred and twenty-two were receIvmg antihyptertensive therapy with drugs listed in Table 2 . Most patients exhibited the anaemia and biochemical abnormalities common in chronic renal failure (Table 3) .
There was no protocol for anaesthesia for renal transplantation during the five years reviewed. The technique employed was selected by the consultant and resident staff participating in each procedure.
RESULTS
Two hundred and sixty-seven anaesthetic record sheets were available for analysis. (Table 4) A narcotic/antimuscarinic combination was used 123 times. One hundred patients received no premedication prior to arrival in the operating theatre. (Table 5)   114  100  27  7  6  4  3  2  2   1  1 Two hundred and sixty-six patients received general anaesthesia. Two hundred and sixtythree patients, including one with a failed epidural anaesthetic, underwent intravenous induction. Thiopentone was used 262 times, Althesin once. Short-acting narcotics were used (Table 6 ). Ninety-one patients, including 14 whose preoperative serum potassium concentration was greater than 5.0 mmolll, received suxamethonium (18 receiving pre-curarisation and 19 Sellick's manoeuvre). Two hundred and one patients received tubocurarine, 44 pancuronium and 16 alcuronium. One patient received a single dose of suxamethonium only. (Table 7) All two hundred and sixty-six patients who had general anaesthesia received nitrous oxide, usually 66070. Fifty-nine patients received a volatile anaesthetic as a supplement, 49 a narcotic, and 153 a combination of both. A small number received other drugs, most commonly a neurolept combination. Eighty-six patients received fentanyl. The dose of Anaesthesia and Intensive Care. Vol. 11, No. 4, November, 1983 nondepolarising muscle relaxant used during induction was followed by increments in 146 patients. 
ANAESTHETIC TECHNIQUE

Premedication
Induction
Maintenance
Reversal
All patients receiving nondepolarising relaxants were reversed with atropine and neostigmine (maximum 2.4 and 5.0 mg respectively). One also received edrophonium 10 mg. The mean duration of the procedure was 2 hours 53 minutes with a range of 1 hour 45 minutes to 6 hours.
BLOOD Loss AND TRANSFUSION
Unfortunately much of this information was recorded primarily on forms destroyed after patient discharge. Blood loss was recorded in 95 cases. The mean loss was 496 ml, with a maximum of 1800 ml. During the study, after the publication of reports 7 demonstrating increased graft survival following pre-and perioperative blood transfusion, the percentage of patients having transfusions increased. COMPLICATIONS 
Cardiac complications
There were no intraoperative deaths. One patient died of cardiac arrest 22 hours postoperatively. Her preinduction blood pressure was 210/110 and averaged 180/90 during the procedure with the lowest recorded level at 130/75. During the recovery period her blood pressure reached 300/150 but was not treated. Oral hypotensive agents (prazosin, hydrallazine and labetolol) were given 3 hours postoperatively and blood pressure gradually settled at 145/70. Serum potassium concentration at this time was 7.1 mmolll and was treated with dextrose, insulin and bicarbonate. Postmortem examination revealed that the patient had an anomalous coronary circulation with only one coronary artery which contained a moderate degree of atheroma. There was no macroscopic myocardial infarction but lesions found on microscopy were thought to be consistent with Liebman-Sachs endocarditis.
Four patients had life-threatening cardiac complications. Two developed ventricular tachycardia. The first of these occurred during a nitrous oxide/oxygen/tubocurarine/ phenoperidine anaesthetic 40 minutes after induction, and was converted to sinus rhythm with lignocaine and external cardiac massage. There were no sequelae. The second patient had an uneventful anaesthetic for his transplant but required exploration for ureteric obstruction later the same day. At the conclusion of that procedure which lasted 1 Yz hours, an episode of ventricular tachycardia occurred. It was successfully cardioverted. The patient was ventilated in the Intensive Care Ward overnight and there were no further problems. Two patients sustained myocardial infarcts in the early postoperative period. The first developed chest pain and infarction 24 hours postoperatively.
Preoperative echocardiography had disclosed cardiomegaly with a poorly contractile left ventricle. Systolic blood pressure throughout the procedure was approximately 140 mmHg, with a sinus tachycardia of 100-11O/min. The rate pressure product reached 15,000. No further sequelae occurred. The second patient developed a supraventricular tachycardia (rate 160/min) following administration of atropine 1.2 mg and neostigmine 2.5 mg. His blood pressure at that time was 200/110 mmHg. Carotid sinus massage was ineffective in slowing his heart rate but verapamil was successful. Postoperative ECG changes indicated a subendocardial infarct. No further problems occurred.
Seventeen patients were noted to have less serious dysrhythmias. Two had supraventricular tachycardias on the second postoperative day. The first had a history of paroxysmal tachycardia, and was transferred to the Intensive Care Ward where he received cardioversion. His operative course had been uneventful; there were no sequelae. The second patient had a paroxysmal atrial tachycardia and was reverted with verapamil, again with no sequelae.
Sinus bradycardia (pulse rate < 50/min) was the most common dysrhythmia, recorded in 15 patients, nine of whom were taking betablockers. It was not associated with any serious problems.
Hypotension
The systolic blood pressure of 73 patients (27070) was recorded as dropping by more than 25% of the preinduction level. One patient's transplant procedure was abandoned following severe hypotension at induction. He presented to theatre with a serum potassium concentration of 6.2 mmolll and peripheral oedema. His blood pressure became unrecordable following a thiopentone/ tubocurarine induction, but responded to rapid fluid loading. There were no adverse sequelae, and the patient subsequently underwent an uneventful transplantation.
Prolonged muscular inSUfficiency
Four patients required ventilatory support for postoperative muscular insufficiency ( Table  8 ). Three of these did not regain neuromuscular function following administration of neostigmine 5 mg. Their preoperative biochemical profiles did not differ markedly from the general transplant population. The fourth patient had received curare 45 mg and enflurane and appeared to reverse adequately but after 45 minutes in the recovery ward showed signs of inadequate muscular activity 
Respiratory depression
Naloxone in doses up to 0.12 mg was given to treat respiratory depression occurring postoperatively in six patients (Table 9 ).
DISCUSSION
The patients in this study were similar to those reported in other recent, large series. 3 ,8,9 Cardiovascular disease, anaemia, azotaemia and electrolyte abnormalities were common but metabolic acidosis less so. Hyptertension was usually well controlled, congestive cardiac failure was uncommon, and uraemic effusions very unusual.
General anaesthesia using intravenous induction, muscle relaxants, and either narcotic or volatile supplements or both, was the most common technique in this series.
Epidural anaesthesia for renal transplantation has again been advocated in a recent report 6 and has a number of potential advantages, including the avoidance of muscle relaxants. Also, instrumentation of the airway, which may be of importance as a source of bacteraemia in an immunosuppressed and uraemic patient, will not be required.
The greatest cause for concern with epidural anaesthesia is the possibility of epidural haematoma in patients who may have platelet dysfunction secondary to uraemia. Linke 6 has reported a series of 21 epidural anaesthetics for renal transplantation. Technical difficulties necessitated conversion to a general anaesthetic in four cases. These results were much better Anaesthesia and Intensive Care, Vat. 11, No. 4, November, 1983 Fentanyl 200 mcg 0.4 mg than those of Aldrete lO whose series included 22 patients who received continuous epidural anaesthesia. Twenty-one of these ultimately required general anaesthesia. These reports and our adverse experience, albeit limited, have not encouraged any increase in the use of epidural anaesthesia for renal transplantation. Postinduction hypotension (defined as a decrease in blood pressure of 25 % or more of the pre-induction value) was seen frequently. It was recorded more commonly after a thiopentone/nondepolarising muscle relaxant sequence (33%) than after a thiopentone/ s uxamethoni um/ nondepolariser sequence (78%). Lindahl-Nilson 8 et al., who used pancuronium for intubation in 146 cases, reported a similar experience irrespective of whether a neurolept or thiobarbiturate induction was used. Hyptertensive patients could not be shown to be more likely to sustain a fall in blood pressure than normotensive patients which may indicate that these hypertensives were well controlled and, as such, less subject to large changes in pressure than inadequately treated subjects, as demonstrated by Prys-Ro berts. 11 Suxamethonium is commonly used for rapid sequence induction in patients who may have a full stomach. Hyperkalaemia is an important relative contra-indication to its use. In our institution the time taken to tissue-match kidney and recipient and the viability time of the cadaver kidney allow up to eight hours for the stomach to empty and hyperkalaemia to be treated. Patients were dialysed where indicated before surgery. Three patients received glucose and insulin, two bicarbonate administration, and nine both these measures to lower potassium levels acutely before induction. Precurarisation was employed to attenuate the suxamethonium-induced potassium flux in 18 cases. Whilst this may be effective in other situations, its use has not been shown to be effective in patients with renal failure. 12 In this series suxamethonium was used following precurarisation in patients with serum concentrations up to 6.1 mmolll. The accepted maximum serum potassium for the use of suxamethonium without precurarisation was 5.6 mmolll. Above this level, nondepolarising muscle relaxants alone were used. We now feel a safe maximum serum potassium for suxamethonium administration is 5.5 mmolll, an approach in agreement with that of others. 12 The availability of a non depolarising muscle relaxant enabling rapid sequence intubation would be an advantage.
It has been reported that halothane can be associated with serious cardiac dysrhythmias during renal transplantation. 10 The two patients in our series who developed serious perioperative dysrhythmias had not received halothane. However, 13 of the 15 patients who experienced intra-operative bradycardia had received a volatile supplement.
Enflurane was used as volatile supplement in 36 (14070) patients. Cousins et al. 13 have suggested that the already impaired kidney may have a lower threshold for fluoride-induced nephrotoxicity and Wickstrom 14 demonstrated that the use of enflurane during renal transplantation may result in fluoride levels approaching 75% of the level regarded as toxic in the normal kidney. Accordingly, avoidance of its use in anaesthesia for renal transplantation is advised,13 although others have employed it in large numbers of patients without adverse effects. 9 Enflurane potentiates nondepolarising muscle relaxants and has been shown to reduce the dose of pancuronium required during transplantation. 14 Two of our four patients with prolonged neuromuscular insufficiency had received enflurane administered in conjunction with usual, rather than reduced, doses of nondepolarising relaxant. Its use may have contributed to their prolonged neuromuscular blockade.
The new volatile agent isoflurane may be useful in renal transplantation. It has minimal adverse effects on ventricular performance, is usually associated with a stable cardiac rhythm, is subject to negligible biotransformation to fluoride ions, and potentiates the effects of nondepolarising neuromuscular blockers. 15 A disadvantage is the hypotension produced by peripheral vascular dilatation, which is more likely in dehydrated patients.
Tubocurarine was the most commonly used nondepolarising relaxant. Recent reports confirm that tubocurarine is preferable to pancuronium in patients with chronic renal failure because of potentially greater excretion through the hepatobiliary system. 16 However, redistribution is likely to be the main factor terminating the action of any relaxant1 7 ,18 and an initial "intubation" dose and a small supplemental dose will usually enable reversal at the conclusion of the procedure. Alcuronium and gallamine are almost entirely excreted by the kidney, and are contraindicated. However, one of our patients received 89 mg of alcuronium during a 311z-hour transplant and was adequately reversed with a normal dose of neostigmine. It has been demonstrated that newly transplanted kidneys that function immediately can eliminate relaxants effectively in the perioperative period. 16 Three of our patients had delayed recovery of neuromuscular function, a fourth exhibiting "recurarisation". Two had received tubocurarine in total doses that would not be regarded as excessive in normal patients and none of the factors usually associated with prolonged paralysis could be documented. The third had received a moderate dose of alcuronium as a single bolus. She received enflurane as a primary supplement. Because she had had prolonged paralysis in another hospital after pancuronium administration, to exclude a myasthenic tendency, electromyography was ,performed which was normal. However, subsequent investigation revealed that she had developed anti-receptor antibodies and further studies are being undertaken.
The fourth patient required reintubation and ventilation one hour after the conclusion of an anaesthetic during which he had received tubocurarine 45 mg. He was hyponatraemic with a metabolic and respiratory acidosis at the time of reintubation. These factors have been associated with prolonged paralysis and recurarisation although the evidence is complex and conflicting. 18 -2o Monitoring neuromuscular blockade with the peripheral nerve stimulator has demonstrated that profound muscular relaxation is not necessary for renal transplantation to the iliac fossa when a halothane-supplemented anaesthetic is administered. Recognition that the presence of a fourth twitch in the "train of four" mode coincides with this degree of blockade has encouraged a reduction in the doses of tubocurarine currently used. Two new neuromuscular blocking drugs offer the advantage of considerable (norcuron)21 and complete (atracurium)22 independence of renal function for excretion, and are almost devoid of cardiovascular effects. When available, these should be preferable to tubocurarine in patients with renal failure. Despite anticipated problems in reversing neuromuscular blockade, a dose of 2.5 mg of neostigmine usually sufficed. Very occasionally, a second equivalent dose was required. One patient also received edrophonium 10 mg in an attempt to augment reversal. The elimination half-lives of neostigmine,23 pyridostigmine 20 and edrophonium24 are all increased in patients with renal failure, and all may be suitable agents for reversal of neuromuscular blockade.
One of our patients developed supraventricular tachycardia during reversal. Cardiac arrest occurring at this time has been reported previously.3,4 A reversal combination with fewer cardiovascular side effects would be an advantage.
Although naloxone therapy was employed in only six patients, this presents an area for possible improvement. In three of these patients, fentanyl in relatively large doses had been part of the anaesthetic sequence in addition to premedication with omnopon. It is not routine in our institution to manage renal transplant patients in the Intensive Care Ward. In these circumstances, a judicious reduction in the dose of such potent analgesics may be required in addition to close postoperative supervision.
The most impressive result of this survey was the overall safety of renal transplantation using standard anaesthetic techniques. This situation must, in no small way, be due to the improved pre-operative status of the patients. Anticipated problems with hyperkalaemia caused by suxamethonium did not eventuate, either Anaesthesia and Intensive Care. Vol. ll. No. 4, November, 1983 because of pre-operative treatment or because the anaesthetic technique was suitably modified.
The patient who died 22 hours after operation had become severely hypertensive in the recovery area and more vigorous management of this crisis may have averted the subsequent cardiac arrest. This raises the perennial question of exactly where anaesthetic responsibility ends. Four other patients had significant cardiac problems. Although the renal transplant patients are meticulously prepared for theatre, they remain a group to be considered serious anaesthetic risks. It is gratifying that only 5 patients out of 270 had serious cardiac complications.
Only four patients required postoperative ventilatory support, which was fewer than anticipated. It is possible that the concern regarding muscle relaxants in renal transplantation has been overemphasised. The peripheral nerve stimulator permits closer monitoring of neuromuscular function and its use is now routine in our institution.
An interesting but unanticipated finding of this survey was the incidence of post-induction hypotension after the use of a nondepolarising muscle relaxant to facilitate intubation. This has now resulted in our technique being modified to include the more frequent use of suxamethonium for intubation.
In conclusion, our current routine anaesthetic technique for renal transplantation is as follows: intravenous induction, suxamethonium for intubation, tubocurarine (monitored by peripheral nerve stimulator), ventilation with nitrous oxide and oxygen supplemented with small doses of narcotic and halothane, and reversal with neostigmine and atropine.
